Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
| Revenue (Most Recent Fiscal Year) | $23.63B |
| Net Income (Most Recent Fiscal Year) | $509.72M |
| PE Ratio (Current Year Earnings Estimate) | 13.02 |
| PE Ratio (Trailing 12 Months) | 14.77 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.23 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 9.38 |
| Pre-Tax Margin (Trailing 12 Months) | 7.17% |
| Net Margin (Trailing 12 Months) | 1.92% |
| Return on Equity (Trailing 12 Months) | 9.06% |
| Return on Assets (Trailing 12 Months) | 4.17% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.43 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.05 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.50 |
| Inventory Turnover (Trailing 12 Months) | 6.27 |
| Book Value per Share (Most Recent Fiscal Quarter) | $9.52 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.23 |
| Earnings per Share (Most Recent Fiscal Year) | $0.70 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.19 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | -- |
| Free Float | -- |
| Market Capitalization | -- |
| Average Volume (Last 20 Days) | 0.05M |
| Beta (Past 60 Months) | 0.78 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.18 |
| Dividend Yield (Based on Last Quarter) | 1.51% |